DK0693054T3 - Cycloalkylhydroxyurinstoffer og deres anvendelse som lipoxygenaseinhibitorer - Google Patents
Cycloalkylhydroxyurinstoffer og deres anvendelse som lipoxygenaseinhibitorerInfo
- Publication number
- DK0693054T3 DK0693054T3 DK94910604T DK94910604T DK0693054T3 DK 0693054 T3 DK0693054 T3 DK 0693054T3 DK 94910604 T DK94910604 T DK 94910604T DK 94910604 T DK94910604 T DK 94910604T DK 0693054 T3 DK0693054 T3 DK 0693054T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- chain
- date oct
- sec
- optionally
- Prior art date
Links
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- -1 N-hydroxyurea compound Chemical class 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/47—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8095293 | 1993-04-07 | ||
| PCT/JP1994/000567 WO1994022814A1 (en) | 1993-04-07 | 1994-04-05 | Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0693054T3 true DK0693054T3 (da) | 1998-10-19 |
Family
ID=13732846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94910604T DK0693054T3 (da) | 1993-04-07 | 1994-04-05 | Cycloalkylhydroxyurinstoffer og deres anvendelse som lipoxygenaseinhibitorer |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5681858A (da) |
| EP (1) | EP0693054B1 (da) |
| AT (1) | ATE167180T1 (da) |
| CA (1) | CA2160140C (da) |
| DE (1) | DE69411003T2 (da) |
| DK (1) | DK0693054T3 (da) |
| ES (1) | ES2116591T3 (da) |
| WO (1) | WO1994022814A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3179286B2 (ja) * | 1994-05-19 | 2001-06-25 | ファイザー製薬株式会社 | Ｎ−ヒドロキシ尿素系抗炎症剤 |
| US5798383A (en) * | 1994-11-10 | 1998-08-25 | Pfizer Inc. | Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas |
| KR102668696B1 (ko) | 2012-01-12 | 2024-05-29 | 예일 유니버시티 | E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법 |
| GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
| GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| US20180228907A1 (en) | 2014-04-14 | 2018-08-16 | Arvinas, Inc. | Cereblon ligands and bifunctional compounds comprising the same |
| US10071164B2 (en) | 2014-08-11 | 2018-09-11 | Yale University | Estrogen-related receptor alpha based protac compounds and associated methods of use |
| BR112018008918A8 (pt) | 2015-11-02 | 2019-02-26 | Univ Yale | compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120752A (en) * | 1989-12-28 | 1992-06-09 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
| US5476873A (en) * | 1990-07-25 | 1995-12-19 | Abbott Laboratories | Acetylene derivatives having lipoxygenase inhibitory activity |
| ES2095325T3 (es) * | 1990-07-25 | 1997-02-16 | Abbott Lab | Derivados de acetileno con una actividad de inhibicion de la lipoxigenasa. |
| GB9025514D0 (en) * | 1990-11-23 | 1991-01-09 | Wellcome Found | Anti-inflammatory compounds |
| JP3007138B2 (ja) * | 1990-11-27 | 2000-02-07 | ファイザー製薬株式会社 | 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物 |
-
1994
- 1994-04-05 DE DE69411003T patent/DE69411003T2/de not_active Expired - Fee Related
- 1994-04-05 ES ES94910604T patent/ES2116591T3/es not_active Expired - Lifetime
- 1994-04-05 US US08/525,748 patent/US5681858A/en not_active Expired - Fee Related
- 1994-04-05 WO PCT/JP1994/000567 patent/WO1994022814A1/en not_active Ceased
- 1994-04-05 AT AT94910604T patent/ATE167180T1/de not_active IP Right Cessation
- 1994-04-05 EP EP94910604A patent/EP0693054B1/en not_active Expired - Lifetime
- 1994-04-05 DK DK94910604T patent/DK0693054T3/da active
- 1994-04-05 CA CA002160140A patent/CA2160140C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69411003D1 (de) | 1998-07-16 |
| WO1994022814A1 (en) | 1994-10-13 |
| CA2160140C (en) | 1999-03-16 |
| US5681858A (en) | 1997-10-28 |
| EP0693054A1 (en) | 1996-01-24 |
| DE69411003T2 (de) | 1998-10-08 |
| CA2160140A1 (en) | 1994-10-13 |
| EP0693054B1 (en) | 1998-06-10 |
| ATE167180T1 (de) | 1998-06-15 |
| ES2116591T3 (es) | 1998-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0741970A4 (en) | BACTERICIDAL COMPOSITION | |
| IL205420A (en) | Immunogoldular and Derivative Compounds, Pharmaceutical Compounds in the Treatment of Inflammatory Stomach and Gastrointestinal Disorders | |
| AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
| DK0693054T3 (da) | Cycloalkylhydroxyurinstoffer og deres anvendelse som lipoxygenaseinhibitorer | |
| ID26622A (id) | Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide | |
| ATE266401T1 (de) | Nefiracetam zur prophylaxe und behandlung von propofol verursachtem gedächtnisschwund | |
| NO308654B1 (no) | Amid-derivater, fremgangsmÕter og mellomprodukter for fremstilling derav, deres anvendelse og farmasøytiske blandinger som inneholdende dem | |
| DK0907646T3 (da) | Dihydrobenzopyren og lignende forbindelser anvendelige som middel mod betændelse | |
| DE69200665D1 (de) | Lipoxygenase inhibierende Hydroxamsäure und N-Hydroxyharnstoff-Derivate. | |
| ATE171939T1 (de) | Phenoxyphenylcyclopentenyl-hydroxyharnstoffe | |
| DE69315836D1 (de) | Pyrazolpyridine für die behandlung der anämie | |
| IL113706A (en) | N-hydroxyurea alkyl phenyl oxazoles and thiazoles uses thereof as anti-inflammatory agents and pharmaceutical compositions containing them | |
| DK0646110T3 (da) | N-substituerede 3-azabicyclo(3.2.0) heptanderivater som neuroleptika | |
| ITMI922742A1 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattie connesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
| DE69414396D1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten | |
| KR950702533A (ko) | 리폭시게나제 억제제로서의 인돌리닐 n-하이드록시우레아 및 n-하이드록삼산 유도체(indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors) | |
| FI943420A0 (fi) | Heteroaryylisykloalkenyylihydroksiureat | |
| FI935867A0 (fi) | Tetrahydrobensazepinderivat som inhibiterar lipoxigenas | |
| MY107993A (en) | Orally active antiviral compounds. | |
| DK0625140T3 (da) | Cyclopropyl-N-hydroxyurinstof og -N-hydroxyacetamider, som inhiberer lipoxygenase | |
| GEP20053513B (en) | 2-Aminocarbonyl-9H-Purine Derivatives | |
| MX9710034A (es) | Compuestos de bencimidazol. |